Precision medicine. Personal diagnosis. Announcing Next Generation Sequencing.
PLA is pleased to announce Next Generation Sequencing (NGS) for solid tumor biomarker testing is now being performed on site at our laboratory in Tulsa, Oklahoma. PLA is pleased to announce that Next Generation Sequencing (NGS) for solid tumor biomarker testing is now being performed on site at our laboratory in Tulsa, Oklahoma. This will significantly decrease the time waiting for results to help guide treatment decisions for oncology patients in comparison to current send-out testing. We are u...